Chemistry Reference
In-Depth Information
TABLE 2
(Continued)
Type of device
Thickness/
diameter,
—m
Animal
Site of implantation/
surgical procedure
Relative
mass loss
of PHB,
%
Relative
loss of PHB
molecular
weight, %
Time,
months
Links
thin films
and ground
particles
-
rabbit
subcutaneously and
intramuscularly in
the legs
>30*
-
2
59
nonwoven
patch
(consisted of
fibers)
200-600
(of patch)
2-20 (of
fibers)
sheep
on the wall of
pericardium to close
artificial defect and
prevent pericardial
adhesions
>90*
-
24
55
nonwoven
patch
(consisted of
fibers)
200-600
(of patch)
2-20 (of
fibers)
sheep
as transannular
patches on the wall
of right ventricular
outflow tract and
pulmonary artery
>99*
-
12
56
nonwoven
patch (con-
sisted of fibers)
200-600
(of patch)
2-20 (of
fibers)
calve
on the septal of right
atrium to close artifi-
cial septal defect
>99*
-
12
53
nonwoven
patch (con-
sisted of fibers)
200-600
(of patch)
2-20 (of
fibers)
patient
on the wall of
pericardium to close
artificial defect and
prevent pericardial
adhesions
27
-
24
57
microspheres
0.5-0.8
rat
intravenously
8*
-
2
19
microspheres
100-300
mice
intramuscularly in
the legs
0*
-
2
58
Rivet shaped
plate
2300
rabbit
intraosseously, into
the lateral condyle of
femur
<10*
-
6
37
* Indirect data
16.3 APPLICATION OF PHB
16.3.1 Medical Devices on the Base of PHB and PHB in vivo
Biocompatibility
The perspective area of PHB application is development of implanted medical devices
for dental, craniomaxillofacial, orthopedic, cardiovascular, hernioplastic, and skin sur-
gery. A number of potential medical devices on the bases of PHB: bioresorbable sur-
gical sutures [17, 18, 62, 63], biodegradable screws and plates for cartilage and bone
fixation [24, 52], biodegradable membranes for periodontal treatment, surgical meshes
with PHB coating for hernioplastic surgery [24], wound coverings [64], patches for
Search WWH ::




Custom Search